PRESS RELEASE published on 04/28/2025 at 22:10, 1 year ago GENFIT : les données positives de la Phase 2 évaluant elafibranor dans la Cholangite Sclérosante Primitive (PSC) seront présentées en « late breaking » par Ipsen au congrès de l'EASL 2025 GENFIT annonce les résultats positifs de la Phase 2 sur elafibranor dans la Cholangite Sclérosante Primitive (PSC) à l'EASL 2025 GENFIT Maladies Rares Du Foie Elafibranor Cholangite Sclérosante Primitive EASL 2025
PRESS RELEASE published on 04/24/2025 at 22:10, 1 year ago GENFIT : Résultats financiers annuels 2024 et point sur les activités de la Société
PRESS RELEASE published on 04/24/2025 at 22:10, 1 year ago GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update GENFIT reports full-year 2024 financial results and corporate update. Net profit of €1.5 million, Iqirvo® commercial launch in PBC, new ACLF datasets, royalty financing. CEO, Pascal Prigent shares progress and outlook Financial Results GENFIT ACLF Iqirvo® Full-year 2024
BRIEF published on 03/10/2025 at 22:15, 1 year 1 month ago GENFIT's Bondholders Approve Amendments for 2025 OCEANEs Royalty Financing Bondholders Amendments Royalty Financing GENFIT OCEANEs
BRIEF published on 03/10/2025 at 22:15, 1 year 1 month ago Les porteurs d'obligations de GENFIT approuvent les amendements au financement des redevances des OCEANEs 2025 Détenteurs D'obligations GENFIT Amendements Financement Par Redevances Les OCEANE
PRESS RELEASE published on 03/10/2025 at 22:10, 1 year 1 month ago Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs GENFIT's 2025 OCEANEs bondholders approve amendment of terms & conditions, anticipates Royalty Financing closure. Repurchase & Consent Fee details announced Repurchase Bondholders Royalty Financing GENFIT 2025 OCEANEs
PRESS RELEASE published on 03/10/2025 at 22:10, 1 year 1 month ago Royalty Financing avec HCRx : GENFIT annonce l’approbation de la modification des modalités de ses OCEANEs 2025 GENFIT approuve la modification des modalités de ses OCEANEs 2025 avec HCRx, prépare le Rachat et la Contrepartie Financière. Détails et calendrier dans le communiqué de presse Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
BRIEF published on 02/27/2025 at 22:15, 1 year 2 months ago GENFIT Reports Financial Metrics for 2024 Revenue Growth Cash Position Strategic Partnership Milestone Payment GENFIT Financials 2024
BRIEF published on 02/27/2025 at 22:15, 1 year 2 months ago GENFIT publie ses résultats financiers pour 2024 Partenariat Stratégique Croissance Des Revenus Situation De Trésorerie Paiement D'étape Résultats Financiers GENFIT 2024
PRESS RELEASE published on 02/27/2025 at 22:10, 1 year 2 months ago GENFIT Announces Revenues and Cash Position as of December 31, 2024 GENFIT announces revenues of €67.0 million & cash position of €81.8 million as of Dec 31, 2024, with plans for non-dilutive capital financing deal & upcoming financial communications Revenues Cash Position Financial Communications GENFIT Non-dilutive Capital Financing
Published on 05/08/2026 at 01:50, 3 hours 8 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 4 hours 13 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 4 hours 58 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 5 hours 28 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 5 hours 43 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 5 hours 35 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 5 hours 44 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 6 hours 53 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 8 hours 16 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 10 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 9 hours 43 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 9 hours 43 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 9 hours 52 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 9 hours 52 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 9 hours 58 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL